|
|
||
|---|---|---|
| Moderator 主持人 | Alexandra J. Lansky, Runlin Gao 高润霖 | |
| Discussant 讨论者 | Ori Ben-Yehuda, Jun Bu 卜军, Feng Cao 曹丰, Mitchell W. Krucoff, Marie-Angèle Morel, Sahil A. Parikh, Jenny Zhen Qin, Zengwu Wang 王增武 | |
|
8:30 AM- |
Introduction and Objectives 目的简介 |
Alexandra J. Lansky |
|
8:33 AM- |
Welcome Address 欢迎致辞 |
Runlin Gao 高润霖 |
|
8:36 AM- |
Featured Lecture: Perspectives on the Next Chapter of Clinical Research in China 特色讲座：中国临床研究下一章展望 |
Bo Xu 徐波, Martin B. Leon |
|
8:51 AM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
|
|
9:03 AM- |
How to Start and Set up a Thriving Clinical Research Program: The Basics and Balance 怎样开始和设立一个蓬勃发展的临床研究项目：基本要素和平衡考量 |
Sahil A. Parikh |
|
9:18 AM- |
Updates on Global Collaboration in Medical Device Research 医疗器械研究全球合作新进展 |
Mitchell W. Krucoff |
|
9:30 AM- |
Big Data Analysis Using the Chinese Population: A Research Example from Cardiovascular Field 中国人群大数据分析：心血管领域研究实例 |
Zengwu Wang 王增武 |
|
9:45 AM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
|
|
|
||
|---|---|---|
| Moderator 主持人 | Patrick W. Serruys, Yaling Han 韩雅玲 | |
| Discussant 讨论者 | Ori Ben-Yehuda, Christos Bourantas, Alexandra J. Lansky, Roxana Mehran, Tullio Palmerini, Yang Wang 王杨, Ming Zheng 郑明 | |
|
10:00 AM- |
How Much Can We Trust Randomized Trials: The Good, the Bad, and the Ugly (with case examples) 我们可以信任随机试验到什么程度：好的、坏的及丑陋的（含范例） |
Roxana Mehran |
|
10:12 AM- |
Q&A 问答 |
|
|
10:15 AM- |
How Much Can We Trust Observational Registries: The Good, the Bad, and the Ugly (with case examples) 我们可以信任观察性登记研究到什么程度：好的、坏的及丑陋的（含范例） |
Alexandra J. Lansky |
|
10:27 AM- |
Q&A 问答 |
|
|
10:30 AM- |
How Much Can We Trust Meta-Analyses: The Good, the Bad, and the Ugly (with case examples) 我们可以信任荟萃分析到什么程度：好的、坏的及丑陋的（含范例） |
Tullio Palmerini |
|
10:42 AM- |
Q&A 问答 |
|
|
10:45 AM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
|
|
|
||
|---|---|---|
| Moderator 主持人 | Roxana Mehran, Yuejin Yang 杨跃进 | |
| Discussant 讨论者 | Mao Chen 陈茂, Evald H. Christiansen, Rebecca T. Hahn, Martin B. Leon, Akiko Maehara, Patrick W. Serruys, Alan C. Yeung, David X. M. Zhao | |
|
11:00 AM- |
PARTNER 3 and TAVR Trials PARTNER 3和其他TAVR试验 |
Rebecca T. Hahn |
|
11:08 AM- |
Panel Discussion: Criticisms and Strengths - Impact on Clinical Practice 专家讨论：点评优缺点及其对临床实践的影响 |
|
|
11:20 AM- |
GLOBAL LEADERS and GLASSY GLOBAL LEADERS和GLASSY试验 |
Patrick W. Serruys |
|
11:28 AM- |
Panel Discussion: Criticisms and Strengths - Impact on Clinical Practice 专家讨论：点评优缺点及其对临床实践的影响 |
|
|
11:40 AM- |
ULTIMATE ULTIMATE试验 |
Junjie Zhang 张俊杰 |
|
11:48 AM- |
Panel Discussion: Criticisms and Strengths - Impact on Clinical Practice 专家讨论：点评优缺点及其对临床实践的影响 |
|
|
12:00 PM- |
Adjourn 休会 |
|